Invention Grant
US09539221B2 Method of treating airway diseases with β-adrenergic inverse agonists
有权
用β-肾上腺素能反向激动剂治疗气道疾病的方法
- Patent Title: Method of treating airway diseases with β-adrenergic inverse agonists
- Patent Title (中): 用β-肾上腺素能反向激动剂治疗气道疾病的方法
-
Application No.: US10574677Application Date: 2004-10-08
-
Publication No.: US09539221B2Publication Date: 2017-01-10
- Inventor: Richard A. Bond
- Applicant: Richard A. Bond
- Applicant Address: US DE Wilmington AU Melbourne
- Assignee: EGB ADVISORS, LLC,INVION, INC.
- Current Assignee: EGB ADVISORS, LLC,INVION, INC.
- Current Assignee Address: US DE Wilmington AU Melbourne
- Agency: Ditthavong & Steiner, P.C.
- International Application: PCT/US2004/033157 WO 20041008
- International Announcement: WO2005/034871 WO 20050421
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/138 ; A61K31/137 ; A61K31/192 ; A61K31/403 ; A61K31/46 ; A61K31/47 ; A61K31/522 ; A61K31/56
Abstract:
The use of β-adrenergic inverse agonists provides a new and highly efficient way of treating a number of pulmonary airway diseases, including asthma, emphysema, and chronic obstructive pulmonary diseases. In general, such a method comprises administering a therapeutically effective amount of a β-adrenergic inverse agonist to the subject to treat the pulmonary airway disease. Particularly preferred inverse agonists include nadolol and carvedilol.
Public/Granted literature
- US20080254022A1 Method of Treating Airway Diseases With Beta-Adrenergic Inverse Agonists Public/Granted day:2008-10-16
Information query
